Spouting Rock Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Spouting Rock Asset Management's ABBV Position: Q4 2023 in Review
Spouting Rock Asset Management reduced its AbbVie (ABBV) stake by 4.4% in Q4 2023, selling an estimated $41.5K and leaving 6,184 shares worth $958K. The position accounts for 0.35% of the portfolio, ranked #60.
Spouting Rock Asset Management first reported a position in ABBV in Q2 2020 and has held it in 15 quarters since. The position peaked at $3.58M in Q2 2021. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.
- Spouting Rock Asset Management held 6,184 shares of AbbVie worth $958K as of Q4 2023.
- Spouting Rock Asset Management sold 285 AbbVie shares in Q4 2023, an estimated $41.5K.
- AbbVie made up 0.35% of Spouting Rock Asset Management's portfolio in Q4 2023, its #60 holding.
- Spouting Rock Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 15 quarters since.
- Spouting Rock Asset Management's AbbVie position peaked at $3.58M in Q2 2021.
- 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.
Based on Spouting Rock Asset Management's 13F filing for Q4 2023, filed 16 Feb 2024.